
US firm develops weight loss medication to address feline obesity
An American pharmaceutical company has revealed plans to conduct a trial for a new weight loss drug aimed at overweight cats. Okava Pharmaceuticals, headquartered in San Francisco, is preparing to initiate a novel GLP-1 clinical weight loss trial. This study…















